Education for Urology Professionals

For more than 30 years, Grand Rounds in Urology has been a premier, trusted source of quality information and innovative educational tools for professionals in the fields of urology and oncology, including urologists, medical oncologists, radiation oncology physicians, advanced practice providers, industry, and lay audiences. Our content library contains more than 1,000 videos, written commentaries, and presentations on evidence-based research.

Practice Resources for Urology Professionals

For over 30 years, Grand Rounds in Urology has been a premier, trusted source of quality information and innovative educational tools for professionals in the field of urology.

Join our Community

Latest Content Contributions

Our contributing faculty are leaders in their respective fields and drive innovations in urology. Explore their most recent additions.

Empowering Communities: Fostering Prostate Cancer Awareness and Resilience Among Men of Color

Quoc-Dien Trinh, MD, MBA
Mar 2025

Quoc-Dien Trinh, MD, MBA, discusses community outreach and efforts to address racial disparities in prostate cancer outcomes.

Urinary Incontinence (UI) and Overactive Bladder (OAB), Part 1: Prevalence & Risk Factors

Diane Newman, DNP ANP-BC FAAN FAUNA BCB-PMD
Mar 2025

Diane K. Newman, DNP, ANP-BC, FAUNA, FAAN, explores urinary incontinence & overactive bladder, breaking stigma and sharing key insights.

Role of CtDNA in Bladder Cancer

Alexandra Drakaki, MD, PhD
Mar 2025

Alexandra Drakaki, MD, PhD, explores circulating tumor DNA in bladder cancer, highlighting its potential as a biomarker.

PROWESS: (PROstate Cancer Wearables, Exercise, and Structured Supports)

Jamie Jacobs, PhD
Mar 2025

Jamie Jacobs, PhD, presents a talk on the PROWESS study for Black and Latino men with metastatic prostate cancer undergoing ADT.

Role of DNA Repair Mutations in Sensitivity to Cisplatin-based Chemotherapy

Gopalkumar Iyer, MD
Mar 2025

Gopalkumar Iyer, MD, explores the role of genomic alterations in predicting response to neoadjuvant chemotherapy for muscle-invasive bladder cancer.

Utilization and Disparity in Prostate Cancer Risk Assessment Tools

Michael S. Leapman, MD
Mar 2025

Michael Leapman, MD, MHS, delivers a presentation on disparities and utilization patterns of prostate cancer risk assessment tools.

UroEdge™ Learning Centers

The latest best practices from leading urologists, designed to create topic mastery.

Next Generation Functional and Reconstructive Urology

Amy Collier
Mar 2024

Functional and Reconstructive Urology (FRU) is a rapidly expanding subspecialty in Urology. Some may call it rebranding, others call it a blending of existing subspecialties including Female Urology, Neuro-urology, Urodynamics, BPH, Prosthetic Urology, Men’s Health and Reconstructive Urology. Regardless of the name, the vision of the subspecialty is to improve the management of patients with urinary...

Next Generation Men’s Health

David Utz
Sep 2023

This Men's Health NGLC covers topics in Andrology, AUA Guidelines, Sexual Health, Incontinence, BPH, and other topics in Men's Health.

Next Generation Focal Therapy Learning Center

David Utz
Apr 2023

As a result of an increasing amount of clinical data, interest in focal ablation for the treatment of localized prostate cancer has grown immensely over the last fifteen years. We are Drs. Arvin George, Abhinav Sidana, and Jonathan S. Fainberg, internationally-recognized experts in focal therapy. As editors of the Grand Rounds in Urology Next Generation Focal...

Next Generation Microbiome and Urologic Infections

Ben Eppard
Apr 2020

There is an abundance of evidence that the human microbiome plays an important and nuanced role in controlling human health, including metabolism, immunity, pain, psychological state, and cancer.

Next Generation Genomics and Biomarkers

Leonard G. Gomella, MD, FACS
Mar 2019

The role of genetic testing for prostate cancer risk is a rapidly changing area. Experts debate the indications of sending a patient on to genetic counseling for further potential screening for inherited prostate cancer risk. One major issue that needs to be addressed in the urology community today is recognizing the frequency of inherited mutations that...

Next Generation nmCRPC

David Utz
Dec 2018

Latest prostate cancer research is turning its focus on the M0 space. Many therapeutic options for castration-resistant prostate cancer are approved and used for metastatic castration-resistant prostate cancer (mCRPC), but fewer options exist for those with non-metastatic (NM) CRPC.

Next Generation Imaging

David Utz
Dec 2018

The role of imaging is paramount in this evolution by providing physicians with accurate information on both the presence and extent of prostate cancers. Developments in molecular imaging are paving the way for more physicians to diagnose cancer and apply relevant therapy.

Next Generation Androgen Deprivation Therapy

Celestia S. Higano, MD
Oct 2018

One of the major treatments for prostate cancer is androgen-deprivation therapy (ADT), and about 50% of prostate cancer patients are treated with ADT at some point in their disease. ADT is used most frequently for patients with local but advanced prostate cancer or metastatic prostate cancer.

Next Generation Nocturia

Kevin T. McVary, MD, FACS
Aug 2018

Nocturia is arguably the most bothersome lower urinary tract symptom and necessarily imposes a considerable burden on quality of life. The often-multifactorial etiologies contributing to nocturia obscure the establishment of a reliable diagnosis.

Bladder with low grade papillary urothelial carcinoma.

Next Generation Urothelial Carcinoma

Seth P. Lerner, MD, FACS
Aug 2018

Upper tract urothelial carcinoma (UTUC) is cancer of the transitional urothelial cells that line the upper urothelial tract of the renal pelvis and ureter. This type of cancer accounts for between 5% and 10% of urothelial cancer cases.

Latest Features and Updates

Timely information from our GRU Editorial Team, such as newly published proceedings, upcoming events, and newsworthy activities from within the urology community.

Presentations from the 35th Annual International Prostate Cancer Update

Mar 2025

These lectures were presented during the 35th Annual International Prostate Cancer Update in February 2025, in Vail, Colorado.

Presentations from 1st International Functional and Reconstructive Urology Update

Sep 2024

These lectures were presented during the Presentations from 1st International Functional and Reconstructive Urology Update in August 2024, in Denver, Colorado.

Presentations from the 24th Annual Future Directions in Urology Symposium

Sep 2024

These lectures were presented during the 24th Annual Future Directions in Urology Symposium in August 2024, in Colorado Springs, Colorado.

Presentations from the 34th Annual International Prostate Cancer Update

Mar 2024

These lectures were presented during the 33rd Annual International Prostate Cancer Update in January 2023, in Vail, Colorado.

Presentations from the 33rd Annual International Prostate Cancer Update

Feb 2023

These lectures were presented during the 33rd Annual International Prostate Cancer Update in January 2023, in Vail, Colorado.

Presentations from the 6th International Bladder Cancer Update

Dec 2022

These lectures were presented during the 6th Annual International Bladder Cancer Update on November 18, 2022, in Scottsdale, Arizona.

Presentations from the 2nd Annual Advances in Men’s Health

Oct 2022

These lectures were presented during the 2nd Annual Advances in Men's Health in August 2022, in Big Sky, Montana.

Presentations from the 32nd Annual International Prostate Cancer Update

Apr 2022

These lectures were presented during the 32nd Annual International Prostate Cancer Update in March 2022, in Snowbird, Utah.

ADT as Foundational Therapy, and the Need for Consensus on Consistent T Suppression, Goals, Monitoring, and Delaying Time to CRPC

Feb 2022

In a program supported by Verity Pharmaceuticals, E. David Crawford, MD, Editor-in-Chief of Grand Rounds in Urology and Professor of Urology at the University of California, San Diego; Neal D. Shore, MD, FACS, Medical Director for the Carolina Urologic Research Center; and Benjamin H. Lowentritt, MD, FACS, Director of Prostate Cancer Services for United Urology Group...

Presentations from the 1st Annual Advances in Men’s Health

Oct 2021

These lectures were presented during the 1st Annual Advances in Men's Health conference in August 22-25, in Whitefish, Montana.

Presentations from the 31st Annual International Prostate Cancer Update

Aug 2021

These lectures were presented during the 31st Annual International Prostate Cancer Update in July 2021, in Snowbird, Utah.

Lecture Series: Leveraging the Electronic Medical Record to Improve Prostate Cancer Care

Aug 2021

In a GRU exclusive series, Franklin Gaylis, MD, FACS, discusses how the urology field can use the electronic medical record, or EMR, to improve adherence to best medical practices in prostate cancer care.

Screening and Prevention of Prostate Cancer 2021 Series

Jul 2021

In a GRU exclusive series, Sigrid V. Carlsson, MD, PhD, MPH, discusses PSA screens, biopsy, and MRI for early detection.

Androgen Society 3rd Annual Meeting Review with Abraham Morgentaler, MD, FACS

Jul 2021

In a GRU exclusive, Abraham Morgentaler, MD, FACS, Associate Clinical Professor of Urologic Surgery at Harvard University, reviews lectures from all three days of the 3rd Annual Androgen Society meeting.

Presentations from the 4th International Bladder Cancer Update

May 2021

These lectures were presented during the 4th Annual International Bladder Cancer Update on April 28.

Active Surveillance 2021 with Laurence Klotz, MD, FRCSC

Mar 2021

In a GRU exclusive, Laurence Klotz, MD, FRCSC, Professor of Surgery and holder of the Sunnybrook Chair of Prostate Cancer Research at the University of Toronto, gives three Platinum Lectures on the current state of active surveillance for prostate cancer.

Presentations from the Virtual Southwest Prostate Cancer Symposium

Jan 2021

These lectures were presented during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer, presented over four successive weeks throughout October, 2020.

Presentations from Perspectives in Urology Point-Counterpoint Virtual 2020

Dec 2020

These lectures were presented during the Perspectives in Urology Point • Counterpoint Virtual Conference on November 11, 2020.

Presentations from the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer

Dec 2020

These lectures were presented during the 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer, presented over four successive weeks throughout October, 2020.

Southwest Prostate Cancer Symposium

Nov 2020

The 2020 Virtual Southwest Prostate Cancer Symposium (SPCS 2020) is intended for urologists, radiation oncologists, medical oncologists, and other healthcare professionals involved in the treatment of prostate cancer. It will educate the attendees about advances in the management of localized and advanced prostate cancer, with a focus on imaging, technology, and training in the related devices.

Upcoming Live & Virtual Events

Plan your next urology meeting, CME activity or virtual conference now.

29th Annual Innovations in Urologic Practice

Inn and Spa at Loretto
Santa Fe, New Mexico
September 2025

Southwest Prostate Cancer Symposium

TBD
October 23-25, 2025

12th Urology Today Conference

Omni Grove Park Inn
Asheville, North Carolina
October 31 – November 2, 2025

View All